Area of research
Infectious Diseases · Hepatology
Research interest
Research interests include Hepatitis C virus research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Hepatitis B Virus Studies.
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
Joint statement in support of hepatitis C human challenge studies
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data
Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination
Evaluating a digital sepsis alert in a London multisite hospital network: a natural experiment using electronic health record data
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus
Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights
The Global Burden of Cancer 2013
Global distribution and prevalence of hepatitis C virus genotypes
Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy
Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial
Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis